Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hormonal Replacement Therapy in Heart Failure Focus on Growth Hormone and Testosterone
Andrea Salzano et al.
HEART FAILURE CLINICS (2019)
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
David A. McAllister et al.
CIRCULATION (2018)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the TOSCA. Registry
E. Bossone et al.
INTERNAL AND EMERGENCY MEDICINE (2018)
Growth Hormone Therapy in Heart Failure
Andrea Salzano et al.
HEART FAILURE CLINICS (2018)
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
Anders Jorsal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the TOSCA. GHD Study
Michele Arcopinto et al.
PLOS ONE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure
Alberto M. Marra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction
Andrea Salzano et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
John J. Lepore et al.
JACC-HEART FAILURE (2016)
Hormone replacement therapy in heart failure
Michele Arcopinto et al.
CURRENT OPINION IN CARDIOLOGY (2015)
Multiple hormone deficiencies in chronic heart failure
Michele Arcopinto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dehydroepiandrosterone and its Sulfate Predict the 5-Year Risk of Coronary Heart Disease Events in Elderly Men
Asa Tivesten et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Growth Hormone Therapy in Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction: A Meta-Analysis
Nicholas Tritos et al.
Endocrine Practice (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Growth Hormone Replacement Delays the Progression of Chronic Heart Failure Combined With Growth Hormone Deficiency An Extension of a Randomized Controlled Single-Blind Study
Antonio Cittadini et al.
JACC-HEART FAILURE (2013)
Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study
Martin Stout et al.
AMERICAN HEART JOURNAL (2012)
Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction Prevalence, Therapies, and Outcomes
Benjamin A. Steinberg et al.
CIRCULATION (2012)
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Antonio Cittadini et al.
DIABETES (2012)
An unusual case of dilated cardiomyopathy associated with partial hypopituitarism
Alberto Maria Marra et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Testosterone and heart failure
Maurizio Volterrani et al.
ENDOCRINE (2012)
Impaired endothelial- and nonendothelial-mediated vasodilation in patients with acute or chronic hypothyroidism
Raffaele Napoli et al.
CLINICAL ENDOCRINOLOGY (2010)
Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79
Robin Haring et al.
EUROPEAN HEART JOURNAL (2010)
Low serum testosterone and increased mortality in men with coronary heart disease
Chris J. Malkin et al.
HEART (2010)
Testosterone Therapy in Women With Chronic Heart Failure A Pilot Double-Blind, Randomized, Placebo-Controlled Study
Ferdinando Iellamo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Testosterone and heart failure
Chris J. Malkin et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Heart Failure as a Multiple Hormonal Deficiency Syndrome
Luigi Sacca
CIRCULATION-HEART FAILURE (2009)
Androgen-Androgen Receptor System Protects against Angiotensin II-Induced Vascular Remodeling
Yasumasa Ikeda et al.
ENDOCRINOLOGY (2009)
Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure
Mikkel Andreassen et al.
GROWTH HORMONE & IGF RESEARCH (2009)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Christopher M. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction
Antonio Cittadini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure A Double-Blind, Placebo-Controlled, Randomized Study
Giuseppe Caminiti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Insulin resistance in chronic heart failure: A difficult bull to take by the horns
L. Sacca et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Testosterone protects rat hearts against ischaemic insults by enhancing the effects of α1-adrenoceptor stimulation
S. Tsang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The GH-IGF-I axis and the cardiovascular system: clinical implications
Annamaria Colao
CLINICAL ENDOCRINOLOGY (2008)
Unravelling the enigma of dehydroepiandrosterone: Moving forward step by step
Paul A. Komesaroff
ENDOCRINOLOGY (2008)
The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes
B. Lapauw et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Low serum testosterone and mortality in older men
Gail A. Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome:: A randomized, placebo-controlled study
Alessandro Pingitore et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Insulin-resistant cardiomyopathy
Ronald M. Witteles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study
Kay-Tee Khaw et al.
CIRCULATION (2007)
Thyroid disease and the heart
Irwin Klein et al.
CIRCULATION (2007)
NT-proBNP, IGF-I and survival in patients with chronic heart failure
Mario Petretta et al.
GROWTH HORMONE & IGF RESEARCH (2007)
Association between increased mortality and mild thyroid dysfunction in cardiac patients
Giorgio Iervasi et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Acute effects of triiodothyronine on endothelial function in human subjects
Raffaele Napoli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis
Philippe Le Corvoisier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
Anabolic deficiency in men with chronic heart failure - Prevalence and detrimental impact on survival
Ewa A. Jankowska et al.
CIRCULATION (2006)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Growth hormone- and pressure overload-induced cardiac hypertrophy evoke different responses to ischemia-reperfusion and mechanical stretch
H Strömer et al.
GROWTH HORMONE & IGF RESEARCH (2006)
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
CJ Malkin et al.
EUROPEAN HEART JOURNAL (2006)
The decline of androgen levels in elderly men and its clinical and therapeutic implications
JM Kaufman et al.
ENDOCRINE REVIEWS (2005)
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
W Doehner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Insulin resistance and risk of congestive heart failure
E Ingelsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Mechanisms and models in heart failure the biomechanical model and beyond
DL Mann et al.
CIRCULATION (2005)
Increased carotid atherosclerosis in andropausal middle-aged men
J Mäkinen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
Trends in heart failure incidence and survival in a community-based population
VL Roger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Gonadectomy alters myosin heavy chain composition in isolated cardiac myocytes
KL Golden et al.
ENDOCRINE (2004)
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study
GA Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy
S Adamopoulos et al.
EUROPEAN HEART JOURNAL (2003)
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study
RS Vasan et al.
ANNALS OF INTERNAL MEDICINE (2003)
Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females - Molecular insights into gender differences in atherosclerosis
MKC Ng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes
KL Golden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Acute effects of growth hormone on vascular function in human subjects
R Napoli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Androgens and cardiovascular disease
PY Liu et al.
ENDOCRINE REVIEWS (2003)
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies
A Cittadini et al.
EUROPEAN HEART JOURNAL (2003)
Low-T3 syndrome - A strong prognostic predictor of death in patients with heart disease
G Iervasi et al.
CIRCULATION (2003)
Effect of testosterone on post-myocardial infarction remodeling and function
M Nahrendorf et al.
CARDIOVASCULAR RESEARCH (2003)
Hormonal profile in patients with congestive heart failure
PE Kontoleon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
Administration of growth hormone to patients with advanced cardiac heart failure:: effects upon left ventricular function, exercise capacity, and neurohormonal status
M Acevedo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
Growth hormone, acromegaly, and heart failure: an intricate triangulation
L Sacca et al.
CLINICAL ENDOCRINOLOGY (2003)
Endogenous sex hormones and cardiovascular disease in men
M Muller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effect of congestive heart failure on the insulin-like growth factor-1 system
A Anwar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease - A population-based case-control study
A Juul et al.
CIRCULATION (2002)
Sex hormones and hypertension
RK Dubey et al.
CARDIOVASCULAR RESEARCH (2002)
Growth hormone corrects vascular dysfunction in patients with chronic heart failure
R Napoli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Impact of hyperthyroidism and its correction on vascular reactivity in humans
R Napoli et al.
CIRCULATION (2001)
Growth hormone treatment in dilated cardiomyopathy
A Perrot et al.
JOURNAL OF CARDIAC SURGERY (2001)
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
N Suskin et al.
EUROPEAN HEART JOURNAL (2000)
Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine
F Broglio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
